Twinrix vaccine syringeml
Ended Awarded Last action
- Contract number
- SPE2D326F3314
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,275
Award facts
- Contract value 100% obligated
- $12,274.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $12,274.65 to DMS Pharmaceutical Group Inc. for Twinrix vaccine syringes on January 7, 2026, with completion targeted for January 8, 2026. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected through firm fixed-price procurement without a set-aside designation. This delivery order falls under the company's broader Indefinite Delivery Contract with the DLA, the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
The PPV-G GEN V contract awarded to DMS Pharmaceutical Group in November 2025 carries a ceiling value of $499,999,999 and extends through December 31, 2036, comprising a 30-month base period with three optional 30-month extension periods. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial performance across diverse product categories including vaccines, specialty pharmaceuticals, biologics, and routine medications. The company's established contracting activity and competitive capability in unrestricted federal procurement positions it to fulfill the recurring and specialized pharmaceutical requirements of the military medical system globally.
Quick answers
Who was awarded contract SPE2D326F3314?
SPE2D326F3314 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on January 7, 2026.
How much is contract SPE2D326F3314 worth?
The government has obligated $12,275 on SPE2D326F3314.
Is contract SPE2D326F3314 an order under another contract?
Yes. SPE2D326F3314 is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D326F3314 competed?
The extent of competition for SPE2D326F3314 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award